We provide you with 20 years of free, institutional-grade data for VACC stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of VACC. Explore the full financial landscape of VACC stock.
| Reported Date | CIK | Ticker | Type |
|---|
Vaccitech plc(NASDAQ:VACC) 
Vaccitech plc is a biotechnology company developing vaccines and immunotherapies for infectious diseases and cancer, such as hepatitis B, HPV and prostate cancer.
Share this website to your friends
The information provided in this report about VACC stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.